<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">AAPS J</journal-id><journal-id journal-id-type="iso-abbrev">AAPS J</journal-id><journal-id journal-id-type="pmc-domain-id">792</journal-id><journal-id journal-id-type="pmc-domain">aapsj</journal-id><journal-title-group><journal-title>The AAPS Journal</journal-title></journal-title-group><issn pub-type="epub">1550-7416</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC3085705</article-id><article-id pub-id-type="pmcid-ver">PMC3085705.1</article-id><article-id pub-id-type="pmcaid">3085705</article-id><article-id pub-id-type="pmcaiid">3085705</article-id><article-id pub-id-type="pmid">21387146</article-id><article-id pub-id-type="doi">10.1208/s12248-011-9264-y</article-id><article-id pub-id-type="publisher-id">9264</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Use of a Local Sensitivity Analysis to Inform Study Design Based on a Mechanistic Toxicokinetic Model for &#947;-Hydroxybutyric Acid</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Felmlee</surname><given-names initials="MA">Melanie A.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Krzyzanski</surname><given-names initials="W">Wojciech</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Morse</surname><given-names initials="BL">Bridget L.</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Morris</surname><given-names initials="ME">Marilyn E.</given-names></name><address><phone>+1-716-6454839</phone><fax>+1-716-6453893</fax><email>memorris@buffalo.edu</email></address><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1">Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, The State University of New York, Amherst, New York 14260 USA </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>3</month><year>2011</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2011</year></pub-date><volume>13</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">196257</issue-id><fpage>240</fpage><lpage>254</lpage><history><date date-type="received"><day>15</day><month>9</month><year>2010</year></date><date date-type="accepted"><day>21</day><month>2</month><year>2011</year></date></history><pub-history><event event-type="pmc-release"><date><day>09</day><month>03</month><year>2012</year></date></event><event event-type="pmc-live"><date><day>09</day><month>03</month><year>2012</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2016-04-20 04:50:01.083"><day>20</day><month>04</month><year>2016</year></date></event></pub-history><permissions><copyright-statement>&#169; American Association of Pharmaceutical Scientists 2011</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12248_2011_Article_9264.pdf"/><abstract id="Abs1"><p>&#947;-Hydroxybutyric acid (GHB), a drug of abuse, demonstrates complex toxicokinetics with capacity-limited metabolism and active renal reabsorption. The objectives of the present study were to conduct a local sensitivity analysis of a mechanistic model for the active renal reabsorption of GHB and to use the results to inform the design of future studies aimed at developing therapeutic strategies for treating GHB overdoses. A local sensitivity analysis was used to assess the influence of parameter perturbations on model outputs (plasma concentrations and urinary excretion of GHB). Further, a sensitivity index was calculated for each perturbed parameter to assess the specific segments of the time course that are critical to parameter estimation. Model outputs were simulated for rats dosed with 200, 400, 600, and 1,000&#160;mg/kg GHB intravenously and individual parameters were perturbed by two-, five-, and tenfold higher and lower than the nominal value. Model outputs were sensitive to perturbations in clearance and volume parameters. In contrast, model outputs were found to be insensitive to changes in distributional parameters suggesting that additional tissue distribution data is required. Based on the sensitivity analysis the 1,000-mg/kg GHB dose can be eliminated from future studies as the parameters can be adequately estimated from the lower doses. To further validate the use of this model, dose-specific sampling schedules were designed based on model predictions for doses of 600 and 1,500&#160;mg/kg. These sampling schedules were able to adequately capture the inflection point and terminal elimination phase of the plasma concentration&#8211;time profiles obtained.</p></abstract><kwd-group xml:lang="en"><title>Key words</title><kwd>active renal reabsorption</kwd><kwd>gamma-hydroxybutyric acid</kwd><kwd>monocarboxylate transporters</kwd><kwd>sensitivity analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; American Association of Pharmaceutical Scientists 2011</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>